120 related articles for article (PubMed ID: 20936707)
1. Characterizing the contribution of stem/progenitor cells to tumorigenesis in the Pten-/-TP53-/- prostate cancer model.
Abou-Kheir WG; Hynes PG; Martin PL; Pierce R; Kelly K
Stem Cells; 2010 Dec; 28(12):2129-40. PubMed ID: 20936707
[TBL] [Abstract][Full Text] [Related]
2. PTEN loss and activation of K-RAS and β-catenin cooperate to accelerate prostate tumourigenesis.
Jefferies MT; Cox AC; Shorning BY; Meniel V; Griffiths D; Kynaston HG; Smalley MJ; Clarke AR
J Pathol; 2017 Dec; 243(4):442-456. PubMed ID: 29134654
[TBL] [Abstract][Full Text] [Related]
3.
Blee AM; He Y; Yang Y; Ye Z; Yan Y; Pan Y; Ma T; Dugdale J; Kuehn E; Kohli M; Jimenez R; Chen Y; Xu W; Wang L; Huang H
Clin Cancer Res; 2018 Sep; 24(18):4551-4565. PubMed ID: 29844131
[No Abstract] [Full Text] [Related]
4. mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice.
Guertin DA; Stevens DM; Saitoh M; Kinkel S; Crosby K; Sheen JH; Mullholland DJ; Magnuson MA; Wu H; Sabatini DM
Cancer Cell; 2009 Feb; 15(2):148-59. PubMed ID: 19185849
[TBL] [Abstract][Full Text] [Related]
5. Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells.
Mulholland DJ; Kobayashi N; Ruscetti M; Zhi A; Tran LM; Huang J; Gleave M; Wu H
Cancer Res; 2012 Apr; 72(7):1878-89. PubMed ID: 22350410
[TBL] [Abstract][Full Text] [Related]
6. Crosstalking between androgen and PI3K/AKT signaling pathways in prostate cancer cells.
Lee SH; Johnson D; Luong R; Sun Z
J Biol Chem; 2015 Jan; 290(5):2759-68. PubMed ID: 25527506
[TBL] [Abstract][Full Text] [Related]
7. Progression of prostate cancer by synergy of AKT with genotropic and nongenotropic actions of the androgen receptor.
Xin L; Teitell MA; Lawson DA; Kwon A; Mellinghoff IK; Witte ON
Proc Natl Acad Sci U S A; 2006 May; 103(20):7789-94. PubMed ID: 16682621
[TBL] [Abstract][Full Text] [Related]
8. TGFβ signaling limits lineage plasticity in prostate cancer.
Hao Y; Bjerke GA; Pietrzak K; Melhuish TA; Han Y; Turner SD; Frierson HF; Wotton D
PLoS Genet; 2018 May; 14(5):e1007409. PubMed ID: 29782499
[TBL] [Abstract][Full Text] [Related]
9. Single-cell transcriptomics identifies a distinct luminal progenitor cell type in distal prostate invagination tips.
Guo W; Li L; He J; Liu Z; Han M; Li F; Xia X; Zhang X; Zhu Y; Wei Y; Li Y; Aji R; Dai H; Wei H; Li C; Chen Y; Chen L; Gao D
Nat Genet; 2020 Sep; 52(9):908-918. PubMed ID: 32807988
[TBL] [Abstract][Full Text] [Related]
10. Identification of a cell of origin for human prostate cancer.
Goldstein AS; Huang J; Guo C; Garraway IP; Witte ON
Science; 2010 Jul; 329(5991):568-71. PubMed ID: 20671189
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of PRL2 Upregulates PTEN and Attenuates Tumor Growth in Tp53-deficient Sarcoma and Lymphoma Mouse Models.
Nguele Meke F; Bai Y; Ruiz-Avila D; Carlock C; Ayub J; Miao J; Hu Y; Li Q; Zhang ZY
Cancer Res Commun; 2024 Jan; 4(1):5-17. PubMed ID: 38047587
[TBL] [Abstract][Full Text] [Related]
12. A case report of multiple primary prostate tumors with differential drug sensitivity.
Wilkinson S; Harmon SA; Terrigino NT; Karzai F; Pinto PA; Madan RA; VanderWeele DJ; Lake R; Atway R; Bright JR; Carrabba NV; Trostel SY; Lis RT; Chun G; Gulley JL; Merino MJ; Choyke PL; Ye H; Dahut WL; Turkbey B; Sowalsky AG
Nat Commun; 2020 Feb; 11(1):837. PubMed ID: 32054861
[TBL] [Abstract][Full Text] [Related]
13. Immune checkpoint B7-H3 is a therapeutic vulnerability in prostate cancer harboring PTEN and TP53 deficiencies.
Shi W; Wang Y; Zhao Y; Kim JJ; Li H; Meng C; Chen F; Zhang J; Mak DH; Van V; Leo J; St Croix B; Aparicio A; Zhao D
Sci Transl Med; 2023 May; 15(695):eadf6724. PubMed ID: 37163614
[TBL] [Abstract][Full Text] [Related]
14. Sodium selenite increases the activity of the tumor suppressor protein, PTEN, in DU-145 prostate cancer cells.
Berggren M; Sittadjody S; Song Z; Samira JL; Burd R; Meuillet EJ
Nutr Cancer; 2009; 61(3):322-31. PubMed ID: 19373605
[TBL] [Abstract][Full Text] [Related]
15. Single-Cell Analysis Identifies LY6D as a Marker Linking Castration-Resistant Prostate Luminal Cells to Prostate Progenitors and Cancer.
Barros-Silva JD; Linn DE; Steiner I; Guo G; Ali A; Pakula H; Ashton G; Peset I; Brown M; Clarke NW; Bronson RT; Yuan GC; Orkin SH; Li Z; Baena E
Cell Rep; 2018 Dec; 25(12):3504-3518.e6. PubMed ID: 30566873
[TBL] [Abstract][Full Text] [Related]
16. Tgfbr2 inactivation facilitates cellular plasticity and development of Pten-null prostate cancer.
Zhao W; Zhu Q; Tan P; Ajibade A; Long T; Long W; Li Q; Liu P; Ning B; Wang HY; Wang RF
J Mol Cell Biol; 2018 Aug; 10(4):316-330. PubMed ID: 29228234
[TBL] [Abstract][Full Text] [Related]
17. Synthetic essentiality between PTEN and core dependency factor PAX7 dictates rhabdomyosarcoma identity.
Langdon CG; Gadek KE; Garcia MR; Evans MK; Reed KB; Bush M; Hanna JA; Drummond CJ; Maguire MC; Leavey PJ; Finkelstein D; Jin H; Schreiner PA; Rehg JE; Hatley ME
Nat Commun; 2021 Sep; 12(1):5520. PubMed ID: 34535684
[TBL] [Abstract][Full Text] [Related]
18. PTEN, stem cells, and cancer stem cells.
Hill R; Wu H
J Biol Chem; 2009 May; 284(18):11755-9. PubMed ID: 19117948
[TBL] [Abstract][Full Text] [Related]
19. Defining cellular population dynamics at single-cell resolution during prostate cancer progression.
Germanos AA; Arora S; Zheng Y; Goddard ET; Coleman IM; Ku AT; Wilkinson S; Song H; Brady NJ; Amezquita RA; Zager M; Long A; Yang YC; Bielas JH; Gottardo R; Rickman DS; Huang FW; Ghajar CM; Nelson PS; Sowalsky AG; Setty M; Hsieh AC
Elife; 2022 Dec; 11():. PubMed ID: 36511483
[TBL] [Abstract][Full Text] [Related]
20. The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis.
Xin L; Lawson DA; Witte ON
Proc Natl Acad Sci U S A; 2005 May; 102(19):6942-7. PubMed ID: 15860580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
